Laobaixing Pharmacy returns 100 million yuan in temporary working capital
Laobaixing Pharmacy Chain JSC announced the full return of 100 million yuan in idle raised funds that were temporarily used to supplement working capital. The company's board of directors, during its fifth meeting on October 28, 2025, had approved the temporary use of these funds for a period not exceeding two months, as detailed in an announcement on October 29, 2025.
The funds originated from the 2021 non-public issuance of shares, with proceeds arriving on January 27, 2022. The specified period for temporary supplementary working capital was from October 28, 2025, to December 27, 2025.
On December 25, 2025, Laobaixing Pharmacy successfully returned the entire 100 million yuan to the designated special account for raised funds, completing the process ahead of the December 27 deadline. This action confirms that the company has no outstanding balance from the temporary use of these funds.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Laobaixing Pharmacy Chain JSC publishes news
Free account required • Unsubscribe anytime